Magellan’s LeadCare® platform has been used to diagnose lead poisoning for nearly twenty years. The company markets a family of FDA-cleared systems that offer the fastest, simplest way to perform blood lead testing. These range from a point-of-care system used primarily in pediatricians’ offices to higher-throughput systems for diagnostic laboratories. Magellan was acquired by Meridian Bioscience in March 2016.
Location: United States, Massachusetts, Billerica
Investors 1
| Date | Name | Website |
| - | Abingworth... | abingworth... |
Mentions in press and media 6
| Date | Title | Description | Category | Author | Source |
| 16.06.2011 | Life Core ... | The idea is that cooling the b... | - | - | medcitynew... |
| 24.02.2010 | Magellan B... | Magellan Biosciences Inc. tapp... | - | MassDevice... | massdevice... |
| 17.06.2009 | Imalux Cor... | “We are very pleased to have M... | - | - | medcitynew... |
| 01.10.2008 | Pathwork D... | Pathwork Diagnostics, a Sunnyv... | - | - | venturebea... |
| - | Imalux Cor... | Updated 4:40 p.m. CLEVELAND, ... | - | - | medcitynew... |
| - | Life Core ... | Therapeutic hypothermia medica... | - | - | medcitynew... |